COSCIENS Biopharma Statistics
Total Valuation
CSCI has a market cap or net worth of $14.96 million. The enterprise value is -$11.54 million.
Important Dates
The next estimated earnings date is Thursday, November 7, 2024, before market open.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CSCI has 3.12 million shares outstanding. The number of shares has increased by 7.69% in one year.
Shares Outstanding | 3.12M |
Shares Change (YoY) | +7.69% |
Shares Change (QoQ) | +82.90% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 3.74M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.36, with a Debt / Equity ratio of 0.06.
Current Ratio | 3.36 |
Quick Ratio | 2.95 |
Debt / Equity | 0.06 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -2,253.00 |
Financial Efficiency
Return on equity (ROE) is -65.92% and return on invested capital (ROIC) is -39.37%.
Return on Equity (ROE) | -65.92% |
Return on Assets (ROA) | -23.34% |
Return on Capital (ROIC) | -39.37% |
Revenue Per Employee | $409,583 |
Profits Per Employee | -$1.52M |
Employee Count | 12 |
Asset Turnover | 0.10 |
Inventory Turnover | 0.57 |
Taxes
Income Tax | -573,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.40% in the last 52 weeks. The beta is 2.26, so CSCI's price volatility has been higher than the market average.
Beta (5Y) | 2.26 |
52-Week Price Change | -62.40% |
50-Day Moving Average | 4.82 |
200-Day Moving Average | 6.79 |
Relative Strength Index (RSI) | 35.83 |
Average Volume (20 Days) | 5,537 |
Short Selling Information
The latest short interest is 5,268, so 0.53% of the outstanding shares have been sold short.
Short Interest | 5,268 |
Short Previous Month | 5,671 |
Short % of Shares Out | 0.53% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.37 |
Income Statement
In the last 12 months, CSCI had revenue of $4.92 million and -$18.23 million in losses. Loss per share was -$13.94.
Revenue | 4.92M |
Gross Profit | 4.01M |
Operating Income | -18.02M |
Pretax Income | -18.05M |
Net Income | -18.23M |
EBITDA | -17.99M |
EBIT | -18.02M |
Loss Per Share | -$13.94 |
Full Income Statement Balance Sheet
The company has $27.80 million in cash and $1.69 million in debt, giving a net cash position of $26.12 million or $8.38 per share.
Cash & Cash Equivalents | 27.80M |
Total Debt | 1.69M |
Net Cash | 26.12M |
Net Cash Per Share | $8.38 |
Equity (Book Value) | 26.23M |
Book Value Per Share | 8.57 |
Working Capital | 23.31M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$19.27 million and capital expenditures -$655,000, giving a free cash flow of -$19.92 million.
Operating Cash Flow | -19.27M |
Capital Expenditures | -655,000 |
Free Cash Flow | -19.92M |
FCF Per Share | -$6.39 |
Full Cash Flow Statement Margins
Gross Margin | 81.67% |
Operating Margin | -366.71% |
Pretax Margin | -382.56% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -731.63% |